Thetis Pharmaceuticals LLC — Form D/A
Thetis Pharmaceuticals LLC of Ridgefield, CT, a company, filed a Form D amendment with the SEC on 2017-01-17. The offering totals $8.0M, of which $4.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-01-17
- Form: D/A
- Accession: 0001528491-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $4.1M
- Remaining: $3.9M
- Investors: 52
- Date of first sale: 2016-06-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-265832
Issuer
- Name: Thetis Pharmaceuticals LLC
- CIK: 0001528491
- Entity type: Limited Liability Company
- Jurisdiction: CONNECTICUT
- Incorporated: 2011
- Address: 54 Danbury Road, Ridgefield, CT, 06877
- Phone: 203-470-7772
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Gary F Mathias | Director | Southport, CT |
| Walter F Ogier | Director | Winchester, MA |
| Gary F Mathias | Executive Officer | Southport, CT |
| Walter Ogier | Director | Irvine, CA |
| Gary Mathias | Director | Ridgefield, CT |
| Gary Mathias | Executive Officer | Ridgefield, CT |
| Cynthia F Green | Director | New Haven, CT |
| David M Wurzer | Director | Rocky Hill, CT |
| Frank C Sciavolino | Director | Waterford, CT |
| Frank C Sciavolino | Executive Officer | Waterford, CT |
| Dennis F Willson | Director | Devon, PA |
| Alan F Mendelson | Director | West Hartford, CT |
| Dennis M Willson | Director | Devon, PA |
| Michael M Carter | Executive Officer | Southport, CT |
Other filings by this issuer (6)
More